We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RF icon
426
Regions Financial
RF
$26.4B
$3.09M 0.02%
118,793
+4,345
+4% +$95K
PPG icon
427
PPG Industries
PPG
$24.9B
$3.06M 0.02%
23,076
+1,075
+5% +$136K
BR icon
428
Broadridge
BR
$18.4B
$3.04M 0.02%
14,149
-49,813
-78% -$10.4M
ATO icon
429
Atmos Energy
ATO
$29.7B
$3.04M 0.02%
21,889
+1,720
+9% +$221K
HWM icon
430
Howmet Aerospace
HWM
$109B
$3.02M 0.02%
30,144
-3,034
-9% -$274K
CSL icon
431
Carlisle Companies
CSL
$13.5B
$3.02M 0.02%
6,719
+1,129
+20% +$467K
IRM icon
432
Iron Mountain
IRM
$35.9B
$2.97M 0.02%
25,036
-1,044
-4% -$112K
ESI icon
433
Element Solutions
ESI
$8.48B
$2.96M 0.02%
+108,850
New +$2.85M
AME icon
434
Ametek
AME
$53.9B
$2.9M 0.02%
16,868
-9
-0.1% -$1.5K
TTD icon
435
Trade Desk
TTD
$8.97B
$2.88M 0.02%
26,256
+3,273
+14% +$327K
FANG icon
436
Diamondback Energy
FANG
$56B
$2.85M 0.02%
16,511
+935
+6% +$180K
EME icon
437
Emcor
EME
$29.9B
$2.84M 0.02%
6,599
+2,465
+60% +$930K
G icon
438
Genpact
G
$6.22B
$2.84M 0.02%
+72,387
New +$2.62M
STZ icon
439
Constellation Brands
STZ
$22.5B
$2.82M 0.02%
10,949
+1,170
+12% +$290K
HUM icon
440
Humana
HUM
$43.9B
$2.81M 0.02%
8,877
+138
+2% +$49.1K
ROST icon
441
Ross Stores
ROST
$80.8B
$2.78M 0.02%
18,479
-659
-3% -$97.2K
F icon
442
Ford
F
$60.9B
$2.78M 0.02%
263,352
+5,869
+2% +$67.2K
EFX icon
443
Equifax
EFX
$22B
$2.78M 0.02%
9,460
+905
+11% +$255K
CTSH icon
444
Cognizant
CTSH
$26.5B
$2.76M 0.02%
35,725
-1,030
-3% -$76.7K
DASH icon
445
DoorDash
DASH
$84.3B
$2.75M 0.02%
19,250
+5,338
+38% +$647K
DD icon
446
DuPont de Nemours
DD
$18.6B
$2.71M 0.02%
24,217
-180
-0.7% -$18.3K
RDY icon
447
Dr. Reddy's Laboratories
RDY
$9.8B
$2.7M 0.02%
170,000
-30,000
-15% -$483K
HBAN icon
448
Huntington Bancshares
HBAN
$34B
$2.67M 0.02%
181,414
+5,286
+3% +$75.1K
CPRT icon
449
Copart
CPRT
$28.5B
$2.65M 0.02%
50,573
-531
-1% -$27.6K
ERII icon
450
Energy Recovery
ERII
$420M
$2.65M 0.02%
152,232
+30,340
+25% +$479K

Similar funds

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.